Abstract The development of technologies for mass spectrometry imaging is of substantial research interest. Mass spectrometry is potentially capable of providing highly specific information about the distribution of compounds in tissues, with high sensitivity. The in-situ analysis needed for tissue imaging requires MS to be performed under conditions different from the traditional ones, typically with intensive sample preparation and optimized for pharmaceutical applications. In this paper we critically review the current status of MS imaging with different methods of sample ionization and discuss the 3D and quantitative imaging capabilities which need further development, the importance of the multi-modal imaging, and the balance between the pursuit of high-resolution imaging and the practical application of MS imaging in biomedicine.
Introduction
Biological imaging enables correlation of the morphological features inside an organ with pathological symptoms, which is important for finding biomarkers and subsequently using these for disease diagnosis. The distributions of the chemical and biological compounds in organs could obviously be important in the process, but this information was not easily obtained until the use of advanced analytical technology for tissue analysis. With visual observation of H&E (hematoxylin and eosin)-stained tissues being practised in pathology for over a century, modern imaging tools are being developed to provide information about chemical distributions in tissue at molecule-specific levels. Among the different technologies used for tissue imaging, mass spectrometry (MS) is capable of providing molecular information with incomparable specificity and without use of fluorescent or radioactive labels [1] . This highly specific molecule identification is based on measurement of its molecular weight by mass analysis and elucidation of its molecular structure by tandem mass spectrometry or MS/MS analysis. It furnishes a fragmentation pattern specific to the chemical structure of a molecule, which is obtained by energetic excitation of the molecular ions and subsequent mass analysis of the fragment ions.
Mass spectrometry imaging (MSI) is performed by recording mass spectra point by point over a large area on the sample surface and reconstructing artificial images correlating the relative intensities of one or a set of molecules with the original positions in the sample. A wide range of mass analyzers can be selected for MS imaging of different types of analyte or biomarker, including metal elements, organic metabolites, peptides, and proteins. Although mass spectrometry measurement can be very sensitive, the analyte molecules have to be transformed into charged ions and physically sent into a mass spectrometer during the imaging process. This makes MS imaging significantly different from other imaging technology, for example spectroscopic imaging or MRI (magnetic resonance imaging). The efficiency of the methods used for sample ionization is of great importance in MS imaging and its optimization is limited by many practical factors, for example the convenience of the method of ionization and the image resolution required.
Application of any analytical technique to biological and medical applications typically involves two phases, discovery of the biomarkers and routine diagnosis by use of those biomarkers. Although the fundamental principles of the instrumentation and analytical methods are the same, the actual requirements in technical development are usually substantially different for the two phases. The ability to observe wide ranges of chemical and biological compounds is very important for discovery of the biomarkers whereas the convenience of performing biomarker monitoring and compatibility with regulations are extremely important for diagnosis. In this paper we briefly review the imaging capabilities of current MS with the methods most commonly used for sample ionization and discuss their potential and the further development needed for finding biomarkers and performing diagnosis.
Sampling methods
In the history of mass spectrometry, introduction of MS analysis to a new field of application has always been enabled by a breakthrough in methods of ionization. The sensitivity of MS analysis of biological samples is always susceptible to matrix effects and also relies on sophisticated sample cleaning, including extraction and chromatographic separation. Unfortunately, these procedures are not an option for MS imaging of a tissue section, in which analysis of the raw material is necessary to preserve the information on the spatial distribution of the constituents. Thus desorption ionization methods naturally became the first candidates for MS imaging.
Although SIMS (secondary ion mass spectrometry) was the first method widely used for MS imaging of surfaces, MALDI (matrix-assisted laser desorption ionization) imaging was the first popular method used for biological imaging of tissue (Fig. 1a) [2] . MALDI has the advantage of ionizing biomolecules over a wide mass range, including DNA, peptides, and proteins. MALDI MS analysis of extracted proteins relies on mixing of organic matrices with the purified samples; this was modified for MALDI imaging by spraying organic acids, as desorption matrix, over the tissue. Although this adds an additional step to sample preparation and also raises concerns about modification of the original chemical distribution on the tissue surface, it nevertheless results in a powerful MS imaging tool. Although atmospheric-pressure MALDI has recently been used for imaging [3] , MALDI imaging is usually performed in a vacuum environment. SIMS uses a highly energetic primary ion beam impinging the sample surface to generate the secondary ions from the analytes. It has been used for imaging of inorganic and organic surfaces for many years but had not been applied to tissue imaging until the recent success in desorption ionization of large biomolecules by use of "softer" primary beams, for example fullerene ions [4] or other cluster ions of high particle mass (Fig. 1b) . High kinetic energy of the primary ions, in the range 5-25 keV, are used for the SIMS imaging; this requires a high-vacuum environment to reduce the possibility of collisions before the ions reach the tissue surface. SIMS enables highly efficient mapping of metal elements and small molecules (up to m/z 1200) but routine SIMS imaging of large peptides and proteins remains challenging [5] . For both MALDI and SIMS, attempts have been made to enhance sample ionization efficiency by modification of sample substrates and the chemical coatings.
Besides SIMS and MALDI, many other methods of ionization have been developed for mass spectrometry analysis, following the main trend of ionizing larger and larger molecules; this led to evolution of MS applications from elements to organic molecules and, eventually, to biological analysis. In 2004, a new category of methods of ionization, called ambient ionization, emerged, with the clear purpose of direct sampling ionization of raw samples, so MS analysis can be performed without any sample preparation [6] . This philosophy of MS analysis is well suited to imaging of raw tissue and many methods of ambient ionization have been investigated for MS imaging [7] . Desorption electrospray ionization (DESI) is one of the first ambient ionization methods to be intensively applied to tissue imaging ( Fig. 1c ) [8] . It utilizes electrosprayed droplets to sample the tissue surface and generate the secondary ions for MS analysis. The distributions of the drug metabolites, fatty acids, and lipids on the tissues samples could well be characterized by DESI MS imaging.
Although many other features, for example lateral resolution and optimum sensitivity for a particular set of biomarkers, could be considered for selection of an "ideal" method of sample ionization for MS imaging, a primary concern could simply be whether peptides and proteins are expected to be biomarkers for diagnosis. Ambient MS imaging using DESI provides the simplest solution without the need for concern about fixing tissue with special chemical coatings, use of special substrates, or transfer of sample ions into the vacuum for imaging; however, desorption ionization of peptides and proteins with DESI has not been shown to be as efficient as MALDI.
Although obtaining high-resolution MS images and observing a wide range of chemical and biological compounds at high sensitivity will continue to be two main priorities of technological development in MS imaging, other capabilities are also being recognized as essential if MS imaging is to be useful in biomedical applications.
3D MS imaging
As shown by commercially available MRI, X-ray computed tomography (CT), and single-photon emission computed tomography (SPECT), 3D imaging is a powerful means of providing a full set of imaging data enabling studies and diagnosis on the basis of the real spatial distributions of the features of interest. Performing 3D imaging using MS is particularly challenging, because of the need to gain access to molecules in the internal parts of an organ to acquire their spectra. Nevertheless, 3D MS imaging has been investigated in a variety of ways so highly molecule-specific 3D distributions of chemicals can be obtained for tissues. Dynamic desorption for depth profiling uses the probing ion or laser beam to eliminate the tissue layers while performing 2D imaging (Fig. 2a) . A more promising method is to perform 2D imaging of a series of selected sections from an organ and reconstructing 3D images by extrapolation of 2D imaging data (Figs. 2b, c) . Spatial distributions of metabolites, lipids, and proteins have been extracted by use of this method [9] [10] [11] .
Practical difficulties in 3D MS imaging include the intensive work required to obtain large numbers of tissue sections imaged for a sizable organ and the lack of suitable software for processing the data [12] . Five-hundred and sixty sections, each of 20 μm thickness, can be obtained from a mouse brain [10] ; 2D imaging of all these tissue sections would take a very long time, from a month to more than a year, depending on the resolution required. Only a representative set of sections could be imaged; data extrapolation would be needed to fill the gaps in data processing. Few means of processing 3D MS imaging data are yet commercially available. 3D images for a limited number of chemical compounds have been produced and reconstructed without retaining the original MS information, which makes the 3D images completely unsuitable for further data analysis. The amount of raw data is >150 MB for 2D imaging of one section of a mouse brain (approx. 1 cm 2 ) at a low spectral resolution (approx. 1000) and relatively low image resolution (approx. 200 μm). Data reduction [13] is necessary for processing of data in 3D MS imaging with high spectral and spatial resolution. Reconstruction of the 3D data space is also challenged by practical issues, for example, deformation of the tissue sections, misalignment of the sections, and the need for the inter-section intensity normalization. A quantitative measure is needed in 3D imaging to overcome the artificial differences between the 2D images which arise because of section-to-section inconsistency. Properly structured 3D MS data would enable powerful analysis of the features in the spatial distribution of chemicals [9, 12, 14] and enable correlation and comparison of images acquired by use of different methods in multi-modal studies. However, much more effort is required for development of appropriate procedures and software tools capable of data processing in 3D MS imaging.
Quantitative MS imaging
Successful application of mass spectrometry to drug discovery, environmental analysis, and monitoring of compliance with food regulations is highly reliant on the quantitative capability of MS analysis at trace levels. Mass analysis suffers severely from matrix effects, but this has been overcome by appropriate mixing of internal standards with samples. For imaging of intact tissue, direct transfer of this method is somewhat difficult. However, quantification of absolute amounts of chemicals in tissues, with their relative distributions, would enable production of MS images better correlated with information acquired by use of other methods [15, 16] .
Although quantification in MS imaging could be based on external calibration, high accuracy might not be achieved because of tissue heterogeneity and the scan-to-scan variations. For MALDI imaging, quantitation after spraying of internal standards on the sample substrate before placing tissue section, or mixing of internal standards with Fig. 1 Schematic illustrations of MS imaging with (a) MALDI, (b) SIMS, and (c) DESI and ion maps of (a) myelin basic protein (isoform 4) on sectioned rat brain by MALDI imaging [21] , (b) phosphocholine head group on three PC12 cells by SIMS imaging [38] , and (c) phosphatidylserine (PC 40:6) on sectioned rat brain by DESI imaging [8] MALDI matrices to be coated on the tissue section, have been investigated. Accuracy better than 5 % (RSD) has been achieved in quantitation of acetyl-L-carnitine in piglet brain [17] . Quantitative DESI imaging after micro pipetting of internal standards on to selected spots on the tissue sections has also been investigated; relative standard deviation better than 17 % was obtained for a quantitation of clozapine in the brain tissue of dosed rats [18] .
Quantitative MS imaging is still in its infancy. Further development will rely on the development of practically useful procedures for introduction of calibration standards for tissue imaging and for processing of the data obtained. Application of spots of internal standards to selected areas on sample substrates might be of broad applicability for calibration in MS imaging. Significant effects of improvement in quantification will include convenient inter-section normalization for 3D MS imaging, absolute quantification of the distribution of chemicals, and quantitative correlation of MS results with those from other imaging techniques in multimodal studies or diagnosis.
Multimodal imaging
Development, validation, and application of an MS imaging method is a process constantly involving correlation of the molecular distribution observed by use of MS with morphological and cellular features obtained by use of other methods, especially optical images obtained by H&E staining [19] or immunostaining, among others. Multimodal imaging involving MS and other techniques, for example radiography, ultrasound, optical spectroscopy, or MRI, would be very powerful for establishing correlations between histology and pathology, by providing the most complementary and comprehensive information about the object of study or diagnosis [20] . Correlation of MALDI images with optical images and MRI data has been demonstrated for characterization of a tumor in a mouse brain [21, 22] .
Biological samples are very complex. A single tissue section contains a large variety of chemical species ranging from salts, amino acid, lipids, to peptides and proteins. MS imaging could benefit from multi-modal methods of sampling [10] . (c) 3D imaging of mouse kidney with MALDI [39] ionization, because of the different efficiency of sampling of different types of molecules in tissue. Use of several types of methods of sampling ionization, each optimized for different types of molecules, could enhance the overall quality of the MS images. Laser ablation-inductively coupled plasma mass spectrometry (LA-ICPMS) and MALDI (Fig. 3b) have been used for imaging elements and biomolecules, respectively, on adjacent tissue sections from a mouse brain [23] . The images of the elements and lipids were co-recorded with the corresponding optical images. Multimodal imaging of a tissue section with a series of methods has been demonstrated; DESI was followed by MALDI before application of H&E staining to the same tissue section (Fig. 3c) [24] . Chemical information on the distribution of both lipids and proteins was obtained for comparison with histological features. Serial multimodal MS imaging could be applied as a general approach; the sample-treatments for optimization of the individual imaging steps must, however, be compatible with each other and a special sequence of imaging would be critical.
Imaging resolution
As for all imaging techniques, there has been much emphasis on improvement of resolution in MS imaging. Required resolution by default is better than sub-cellular or submicrometer level. This would enable distinction of scattered malignant cells from surrounding healthy cells and enable direct cell-to-cell comparison between MS and optical images of the stained tissue section. The lateral resolution in 2D imaging is largely dependent on sampling probe size, but is also limited by sampling efficiency and the time required to image a sizable sample.
Highest resolution at the 10-nm level has been speculated for SIMS, on the basis of the area of impingement of a single ion; in practice, however, it is impossible to have an ion beam of sufficient intensity consistently focused on such a small area. Resolution below 100 nm has been reported for SIMS imaging of cyanide ( 12 C 14 N) in a mouse cochlea (Fig. 4b) ; this is hard to achieve for imaging of proteins. Resolution in MALDI imaging is generally limited to the size of the laser spot (50-150 μm) but can also be limited by the size of the matrix droplets, which cause diffusion of the analytes on the tissue [25] . MALDI imaging at sub-micron spatial resolution has been reported for cell analysis (Fig. 4a) by use of a transmission mode, in which the laser beam irradiates the rear of the samples [26] . For DESI, the single droplet can be as small as 1 μm in diameter, but the size of the overall sample plume generated by the spray is substantially larger. Highest lateral resolution of 35 μm has recently been reported (Fig.  4c) [27] . On the basis of improved spatial resolution, lipid profiling of mouse ovaries was conducted and temporal changes during the ovulatory cycle were observed and characterized. Instead of making the probe size smaller, an interesting approach has been investigated, in which tissue sections were stretched before imaging. In practice this resulted in improved image resolution [28] . [24] Performing high-resolution MS imaging inevitably results in reduced signal intensity for each sample spot, because of the lower intensity of the probing photons, ions, or charged droplets reaching the spot. The total number of analytes revealed on the sample surface is proportional to imaging resolution whereas the time required for imaging is inversely proportional to resolution. It takes 20 h to image a tissue section approximately 1 cm 2 in area at an image resolution of 50 μm [29] . Further improvement of the resolution requires a much longer time both to cover the larger number of pixels and to spend longer sampling time at each spot. In contrast with spectroscopic imaging, sampling by use of MS probes consumes material on the sample surface, which makes very long sampling impractical. When performing 3D imaging, the ultimate spatial resolution is limited by the thickness of the tissue section for 2D imaging, which is 20 μm. However, the current limitation is the gap between the tissue sections selected for 3D imaging, which can be chosen to be relatively large, to save time when imaging a 3D tissue volume. For example, inter-section resolutions of 130 to 300 μm have been used [10, 30] .
An interesting alternative approach that might lead to a significant improvement in the speed of MS imaging is the method called "microscope MS imaging". Instead of using a fine laser beam to analyze the sample surface pixel by pixel, a relatively large laser beam (hundreds of microns [31] ) is used to desorb and ionize the analytes from the surface. A mass analyzer retaining the lateral positions of the ions, for example time-of-flight, and a position-sensitive detector are needed to obtain the images of the chemical distributions of the entire area sampled. Image resolution in the micron range has been claimed for microscope MALDI imaging of whole-rat cross sections and rat brain sections [32] . The speed of MS imaging could be improved by 2-4 orders of magnitude in microscope mode, and image resolution would be highly dependent on the retention of the relative positions of the chemical species during the ionization and MS analysis.
Diagnostic tissue profiling
We hope pathologists will soon be able to use the moleculespecific information provided by MS imaging to identify the tumor margin for surgery, instead of the examination of the stained tissue, which is a process highly dependent on the pathologist's experience. The high spatial resolution MS imaging taking tens of hours may not be practical or necessary for tumor surgery. Rapid profiling of tissue [33] might serve as a solution for real-time tissue examination (Fig. 5a ). Profiling could be performed on a tissue section taken from the patient during a surgery, and real-time chemical profiling of organs has also been investigated. Challenges to achieving this include safe ionization of the chemicals in the organ in a manner compatible with the surgical procedure and efficient transfer of the ions to a mass spectrometer for analysis. It has been demonstrated that aerosol containing tissue analytes can be Fig. 5 (a) A DESI profiling of human liver adenocarcinoma. The red plots show the trend of signal intensity for three ions (m/z 703, 725, 741) from the non-tumor and tumor tissue [6] . (b) Real-time analysis of tissue with different ionization methods: sonic spray mass spectrometry combined with ultrasonic surgical aspiration, and ultraviolet and infrared laser desorption ionization [35, 36] . (c) Setup of rapid evaporative ionization based on electrosurgical unit for real-time analysis of tissue. A porcine kidney was tested with rapid evaporative ionization in profiling to distinguish the three parts of the kidney: squares, cortex; filled circles, medulla; empty circles, pelvis [34] generated directly from an organ during excision by electrosurgery [34] and laser surgery [35] . By use of a Cavitron ultrasonic surgical aspirator combined with a Venturi device, gaseous particles were transferred over several meters to a mass spectrometer, where they were sampled and ionized by a sonic-spray (Figs. 5b, c) [36] .
Outlook
Mass spectrometry brings to tissue imaging the potential to quantify, with high specificity, a wide range of chemical and biological compounds in tissues. Direct tissue analysis forces use of MS under conditions substantially different from those used for pharmaceutical applications, which involve intensive sample preparation for highly sensitive and highly quantitative results. Tandem mass spectrometry, which is crucial for ultimate specificity, is not yet routinely used in MS imaging because of the amount of time and sample required for compounds in a relatively wide mass range. Rapid survey of a large area at low mass resolution and low image resolution combined with zoom-in scans of target areas with high resolution and MS/MS at selected masses might be necessary to make MS imaging practically useful for biomedical research. Data processing capability for MS imaging must certainly be improved much further to handle large data files, quantify abundances, perform statistical analysis, and compare the images acquired by MS and other techniques. Appropriate combination of ambient ionization methods with miniature mass spectrometers [37] might also produce small benchtop tissue imagers or profilers for the biologists or physicians in the future.
